Introducing the Mispa i200, a cutting-edge Automatic Chemiluminescence Analyzer, designed to revolutionize diagnostic capabilities in medical laboratories. Tailored for medium to large-scale healthcare facilities, the Mispa i200 offers a comprehensive range of tests including thyroid function, autoimmune diseases, anemia, fertility hormones, prenatal screening, bone metabolism, tumor markers, and infectious diseases.

At its core, the Mispa i200 utilizes Acridinium Ester (AE) Direct Chemiluminescence hormone Immunoassay Technology, ensuring high sensitivity and specificity. It boasts an impressive throughput of 200 tests per hour, with a time to the first result of just 14 minutes, enhancing laboratory productivity significantly.

Key features include a sample module with a 50-sample loading capacity, accommodating various sample types such as serum, plasma, whole blood, and urine. The system is designed to prioritize STAT samples and includes features like foam/clot detection, volume tracking, and collision-avoidance to ensure accuracy and reliability.

The reagent module is equally impressive, offering 20 refrigerated positions maintained between 2-8 ºC, with real-time management through Radio Frequency Identification Card (RFID). This module supports online replacement of reagents and employs advanced magnetic bead technology for sample processing.

Ease of use is a priority, with the Mispa i200 runs on sample first protocol featuring a user-friendly LCD touchscreen interface. Its remote diagnosis system, automatic startup and shutdown functions, and bi-directional communication capabilities ensure seamless integration into your laboratory’s existing workflow.

In summary, the Mispa i200 represents a significant leap forward in laboratory diagnostics, offering unparalleled precision, efficiency, and ease of use. It’s an indispensable tool for medical laboratories aiming to enhance their diagnostic capabilities and improve patient outcomes.